Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 28,097 followers.

#JITC Case Report: Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab https://t.co/kGjp4R7ptm https://t.co/4i1SabK7RH

RT @sitcancer: New #JITC Case Report: Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab http…

RT @sitcancer: New #JITC Case Report: Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab http…

New #JITC Case Report: Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab https://t.co/qOVp1AXcbx https://t.co/Z7Bg7fm04A

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.